Success Metrics

Clinical Success Rate
87.5%

Based on 7 completed trials

Completion Rate
88%(7/8)
Active Trials
2(17%)
Results Posted
71%(5 trials)
Terminated
1(8%)

Phase Distribution

Ph phase_2
3
25%
Ph not_applicable
1
8%
Ph phase_4
2
17%
Ph phase_3
6
50%

Phase Distribution

0

Early Stage

3

Mid Stage

8

Late Stage

Phase Distribution12 total trials
Phase 2Efficacy & side effects
3(25.0%)
Phase 3Large-scale testing
6(50.0%)
Phase 4Post-market surveillance
2(16.7%)
N/ANon-phased studies
1(8.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

77.8%

7 of 9 finished

Non-Completion Rate

22.2%

2 ended early

Currently Active

2

trials recruiting

Total Trials

12

all time

Status Distribution
Active(2)
Completed(7)
Terminated(2)
Other(1)

Detailed Status

Completed7
Recruiting2
Terminated1
Withdrawn1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
12
Active
2
Success Rate
87.5%
Most Advanced
Phase 4

Trials by Phase

Phase 23 (25.0%)
Phase 36 (50.0%)
Phase 42 (16.7%)
N/A1 (8.3%)

Trials by Status

terminated18%
withdrawn18%
recruiting217%
unknown18%
completed758%

Recent Activity

2 active trials
Showing 5 of 12
recruitingphase_3

Phase 3 Study of Fibrinogen Concentrate (CSL511) in Subjects With Pseudomyxoma Peritonei Undergoing Cytoreductive Surgery

NCT06617897
completedphase_4

Comparison of Fibrinogen Concentrate and Cryoprecipitate in Pediatric Cardiac Surgery Patients

NCT04376762
recruitingphase_3

Fibrinogen Early In Severe Trauma StudY II

NCT05449834
completedphase_3

Early Use of Cryoprecipitate With Major Hemorrhage Protocol (MHP) Activation

NCT04704869
completedphase_3

In Vivo Effects of Fibrinogen Concentrate (FC) Versus Cryoprecipitate on the Neonatal Fibrin Network Structure After Cardiopulmonary Bypass (CPB)

NCT03932240
View all 12 trials

Clinical Trials (12)

Showing 12 of 12 trials
NCT06617897Phase 3

Phase 3 Study of Fibrinogen Concentrate (CSL511) in Subjects With Pseudomyxoma Peritonei Undergoing Cytoreductive Surgery

Recruiting
NCT04376762Phase 4

Comparison of Fibrinogen Concentrate and Cryoprecipitate in Pediatric Cardiac Surgery Patients

Completed
NCT05449834Phase 3

Fibrinogen Early In Severe Trauma StudY II

Recruiting
NCT04704869Phase 3

Early Use of Cryoprecipitate With Major Hemorrhage Protocol (MHP) Activation

Completed
NCT03932240Phase 3

In Vivo Effects of Fibrinogen Concentrate (FC) Versus Cryoprecipitate on the Neonatal Fibrin Network Structure After Cardiopulmonary Bypass (CPB)

Completed
NCT00916656Phase 3

Fibrinogen Concentrate (Human) - Efficacy and Safety Study

Withdrawn
NCT03508141Phase 2

Fibrinogen Early In Severe Trauma studY Junior

Unknown
NCT03037424Phase 3

FIBrinogen REplenishment in Surgery

Completed
NCT03014700Phase 4

Fibrinogen Concentrate vs Cryoprecipitate

Completed
NCT02540434Not Applicable

Trial of RiaSTAP Versus Cryoprecipitate to Lower Operative Transfusions

Terminated
NCT02745041Phase 2

Fibrinogen Early In Severe Trauma studY

Completed
NCT01187225Phase 2

Fibrinogen Concentrate In Children After Cardiac Surgery

Completed

All 12 trials loaded

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
12